Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Technology

Bio-Gene Technology Ltd (ASX:BGT) Stock Rises: Here’s What Investors Need to Know

The company said documentation and product development activities are under way to support the first commercial supply of its Qcide product to Japan. Bio-Gene’s managing director and chief executive attended major meetings in Japan and the United States during the quarter. The company also …

Sonal Goyal | 11 November 2026

Why Are Cosol Ltd (ASX:COS) Shares Trading Higher Today?

In its FY26 result, released on 19 August 2026, Cosol reported underlying EBITDA of just under $10 million for the full year, with second-half EBITDA of $6.3 million compared with $3.4 million in the first half. The company said operating margins improved to 31.2% …

Sonal Goyal | 11 November 2026

DXN Ltd (ASX:DXN) Shares Gain on Cable Landing Station Contract: What’s Behind the Move?

DXN said it entered a binding contract valued at approximately A$4.8 million, or about US$3.4 million, with a global internet company. The work covers the design,Supplyand commissioning of a modular cable landing station solution, to be deployed at a Pacific region site under US …

Sonal Goyal | 11 November 2026

First Graphene Ltd (ASX:FGR) Stock Climbs: What’s Driving the Gain?

The company said it received an order worth about A$35,000 from an existing customer based in the United States. The graphene is incorporated into electrically conductive inks used in US defence applications, to print circuits and sensors onto flexible and rigid surfaces. The customer …

Sonal Goyal | 11 November 2026

Fluence Corporation Ltd (ASX:FLC) Shares Rise: Why Is the Stock Moving?

Fluence reported year-to-date third-quarter 2026 revenue of $58.0 million, an increase of 11.3% on the prior year. Third-quarter revenue alone was $20.4 million, up 5.8%. Year-to-date EBITDA reached $4.7 million, more than three times the $1.4 million recorded in the prior comparable period, and …

Sonal Goyal | 11 November 2026

Pathkey.AI Ltd (ASX:PKY) Shares Rise on TrialKey Contract: Here’s Why

TrialKey signed a services agreement with Paradigm Biopharmaceuticals, which is under administration, to provide an independent evaluation of its PARA_OA_012 Phase 3 osteoarthritis study. The agreement has a total value of A$25,000 plus GST.

Sonal Goyal | 11 November 2026

Technology Shares Lower Today: 333D, LIFE360 and Nuix in Focus

333D shares were down 12.50% at $0.028 during the session. The company's Appendix 4C and quarterly activities report, released on 29 October 2026, showed cash receipts from customers of $639,558 for the September quarter and total cash and digital asset holdings of $523,880.

Sonal Goyal | 10 November 2026

Energy and Resources Stocks Slip: CRD, BAS and GRV Shares Trade Lower

Conrad shares fell 8.39% to $0.655 during the session. Its quarterly report, released on 28 October 2026, said Indonesia's Ministry of Energy and Mineral Resources approved the farm-down of a 75% non-operated interest in the Duyung PSC to PT Nations Natuna Barat on 27 …

Sonal Goyal | 10 November 2026

Three ASX Tech Stocks Under Pressure: SMN, AER and CF1 Shares Lower

Structural Monitoring Systems shares fell 10.15% to $0.310 during the session. Its Q1 FY27 quarterly report, released on 26 October 2026, showedRevenueof A$7.0 million, against A$8.1 million a year earlier, and net profit after tax of A$0.7 million, against A$1.2 million.

Sonal Goyal | 10 November 2026

Why Is LIFE360 Inc (ASX:360) Trading Lower Today?

Life360 reported total revenue of $174.1 million for the quarter, up 40% year on year. The company said it added 5.3 million monthly active users, taking the total to 107.7 million, and passed 50 million international monthly active users.

Sonal Goyal | 10 November 2026
Support

Hi! How can we help you today?

Loading…